178 related articles for article (PubMed ID: 34709112)
21. Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer.
Wang H; Fan L; Xia X; Rao Y; Ma Q; Yang J; Lu Y; Wang C; Ma D; Huang X
Int J Gynecol Cancer; 2012 Jun; 22(5):755-61. PubMed ID: 22635028
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
Wan J; Shi F; Xu Z; Zhao M
Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer.
Huang K; Geng J; Wang J
Cancer Sci; 2018 May; 109(5):1428-1446. PubMed ID: 29478268
[TBL] [Abstract][Full Text] [Related]
25. LncRNA SNHG7 contributes to cell proliferation, invasion and prognosis of cervical cancer.
Zeng J; Ma YX; Liu ZH; Zeng YL
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9277-9285. PubMed ID: 31773679
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.
Dai C; Xu P; Liu S; Xu S; Xu J; Fu Z; Cao J; Lv M; Zhou J; Liu G; Zhang H; Jia X
Arch Gynecol Obstet; 2021 May; 303(5):1271-1281. PubMed ID: 33151424
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA SNHG7 promotes neuroblastoma progression through sponging miR-323a-5p and miR-342-5p.
Jia J; Zhang D; Zhang J; Yang L; Zhao G; Yang H; Wang J
Biomed Pharmacother; 2020 Aug; 128():110293. PubMed ID: 32534305
[TBL] [Abstract][Full Text] [Related]
28. lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway.
Zhao Y; Hong L
Cancer Biother Radiopharm; 2021 Mar; 36(2):202-210. PubMed ID: 33156701
[No Abstract] [Full Text] [Related]
29. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
[TBL] [Abstract][Full Text] [Related]
30. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
31. LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4.
Huang K; Chen X; Geng Z; Xiong X; Cong Y; Pan X; Liu S; Ge L; Xu J; Jia X
Funct Integr Genomics; 2023 Mar; 23(2):110. PubMed ID: 36995496
[TBL] [Abstract][Full Text] [Related]
32. LncRNA SNHG7 enhances chemoresistance in neuroblastoma through cisplatin-induced autophagy by regulating miR-329-3p/MYO10 axis.
Wang SY; Wang X; Zhang CY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3805-3817. PubMed ID: 32329857
[TBL] [Abstract][Full Text] [Related]
33. SMAD3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
Shi Y; Zhang J; Liu M; Huang Y; Yin L
J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro.
Han Y; Hu H; Zhou J
Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast cancer progression by sponging miRNA-381.
Gao YT; Zhou YC
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6588-6595. PubMed ID: 31378900
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA SNHG7 promotes malignant melanoma progression through negative modulation of miR-9.
Wang W; Liu G; Liu M; Li X
Histol Histopathol; 2020 Sep; 35(9):973-981. PubMed ID: 32365219
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of long non‑coding RNA DDX11‑AS1 inhibits the proliferation, migration and paclitaxel resistance of breast cancer cells by upregulating microRNA‑497 expression.
Liang M; Zhu B; Wang M; Jin J
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169864
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway.
Sun X; Huang T; Liu Z; Sun M; Luo S
Eur J Pharmacol; 2019 Aug; 856():172407. PubMed ID: 31132353
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SNHG7 inhibits proliferation and invasion of breast cancer cells by regulating miR-15a expression.
Li Y; Guo X; Wei Y
J BUON; 2020; 25(4):1792-1798. PubMed ID: 33099915
[TBL] [Abstract][Full Text] [Related]
40. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
